Europe Self Monitoring Blood Glucose (SMBG) Device Market was valued at USD 2.1 Billion in 2022 and is projected to reach USD 4.0 Billion by 2030, growing at a CAGR of 8.4% from 2024 to 2030.
The Europe Self Monitoring Blood Glucose (SMBG) Device Market is experiencing a steady surge, driven by the increasing prevalence of diabetes and the growing demand for reliable and accessible monitoring solutions. SMBG devices enable individuals with diabetes to track their blood glucose levels, allowing them to make real-time decisions regarding their treatment. These devices are essential for maintaining optimal glucose control and are crucial for diabetes management, whether used by patients at home or in clinical settings.
According to recent data, the European market for SMBG devices is projected to grow significantly over the next few years. This growth is largely fueled by rising awareness about diabetes, technological advancements in SMBG devices, and the expanding diabetic population. In particular, countries with high levels of chronic diseases, such as Germany, France, and the UK, are seeing increased demand for more efficient and user-friendly glucose monitoring systems.
The market is divided into various types of SMBG devices, including traditional glucose meters, continuous glucose monitoring (CGM) systems, and flash glucose monitoring devices. Each type offers different features, with CGM systems providing more real-time and comprehensive data. These devices are particularly popular among those with type 1 diabetes or those who need constant glucose tracking. Flash glucose monitoring systems, on the other hand, provide less frequent updates but are less invasive and more affordable.
From an industrial perspective, the demand for SMBG devices is also driven by the need for innovation in health technologies. Manufacturers are focusing on improving the accuracy, ease of use, and integration of SMBG devices with digital health platforms. The growing reliance on digital health tools means that SMBG devices must be compatible with smartphones and other connected devices to allow patients and healthcare professionals to monitor trends, make informed decisions, and track long-term data.
Furthermore, industry players are exploring opportunities in the diabetic care space by integrating these devices with broader wellness technologies. The trend toward preventative healthcare and the rise of telemedicine also play an essential role in shaping the future of the SMBG device market in Europe. With increased investment in research and development, companies are developing next-generation SMBG devices that promise improved accuracy, non-invasiveness, and better overall user experiences.
As the European SMBG market continues to evolve, manufacturers will need to meet both regulatory requirements and consumer expectations for quality, affordability, and user-centric design. The industry’s focus on patient empowerment and personalized care ensures that SMBG devices will remain a critical tool in managing diabetes effectively. This creates ample opportunities for growth, while also encouraging innovations that improve the lives of millions of diabetes patients across Europe.
Get an In-Depth Research Analysis of the Europe Self Monitoring Blood Glucose (SMBG) Device Market Size And Forecast [2025-2032]
Abbott Laboratories
Bionime Corporation
B.Braun Melsungen AG
F.Hoffmann-La Roche Ltd.
LifeScan Inc.
PHC Holdings Corporation
Home Diagnostics Inc.
Terumo Pharmaceutical Solutions
ARKRAY Inc.
Ypsomed Holding AG
Dexcom Inc.
Medtronic PLC.
Novo Nordisk
Glysens Incorporated
Senseonics Holdings
Ascensia
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the Europe Self Monitoring Blood Glucose (SMBG) Device Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the Europe Self Monitoring Blood Glucose (SMBG) Device Market
Blood Glucose Meters
Continuous Glucose Monitoring (CGM) Systems
Smartphone-Integrated Devices
Wearable Glucose Monitoring Devices
Strip-Based
Non-Invasive
Enzyme-Based
Optical Sensors
Diabetes Management
Pre-Diabetes Monitoring
Gestational Diabetes
Fitness and Wellness Tracking
Homecare Settings
Clinics and Diagnostic Labs
Hospitals
Pharmaceutical Companies (for research purposes)
Online Retail
Pharmacies
Hospital Supply Units
Specialty Clinics
US (United States, US and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ Self Monitoring Blood Glucose (SMBG) Device Market Research Analysis
1. Introduction of the Europe Self Monitoring Blood Glucose (SMBG) Device Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Europe Self Monitoring Blood Glucose (SMBG) Device Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Europe Self Monitoring Blood Glucose (SMBG) Device Market, By Type
6. Europe Self Monitoring Blood Glucose (SMBG) Device Market, By Application
7. Europe Self Monitoring Blood Glucose (SMBG) Device Market, By Geography
US
Europe
Asia Pacific
Rest of the World
8. Europe Self Monitoring Blood Glucose (SMBG) Device Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Europe Research and Consulting firm servicing over 5000+ US clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/